Quantification of a number of biogenic amines and their metabolites in brain homogenates by gas chromatography--mass spectrometry. 1984

J Herranen, and A Huhtikangas, and H Tirronen, and T Halonen, and M Huuskonen, and K Reinikainen, and P Riekkinen

A sensitive method is described for the assay of various biogenic amines and their metabolites from brain tissue homogenates. Based on gas chromatography-mass spectrometry and selected ion monitoring, the method allows reliable low-level quantification of the compounds of interest. By careful study of reaction conditions both in the preparation of derivatives for gas chromatography and in the synthesis of deuterated analogues for internal standard use, relatively simple procedures could be applied with good analytical efficiency. Correlation of the results with those obtained by a high-performance liquid chromatographic procedure was also investigated, and a neurologic application of the method is briefly discussed.

UI MeSH Term Description Entries
D008401 Gas Chromatography-Mass Spectrometry A microanalytical technique combining mass spectrometry and gas chromatography for the qualitative as well as quantitative determinations of compounds. Chromatography, Gas-Liquid-Mass Spectrometry,Chromatography, Gas-Mass Spectrometry,GCMS,Spectrometry, Mass-Gas Chromatography,Spectrum Analysis, Mass-Gas Chromatography,Gas-Liquid Chromatography-Mass Spectrometry,Mass Spectrometry-Gas Chromatography,Chromatography, Gas Liquid Mass Spectrometry,Chromatography, Gas Mass Spectrometry,Chromatography, Mass Spectrometry-Gas,Chromatography-Mass Spectrometry, Gas,Chromatography-Mass Spectrometry, Gas-Liquid,Gas Chromatography Mass Spectrometry,Gas Liquid Chromatography Mass Spectrometry,Mass Spectrometry Gas Chromatography,Spectrometries, Mass-Gas Chromatography,Spectrometry, Gas Chromatography-Mass,Spectrometry, Gas-Liquid Chromatography-Mass,Spectrometry, Mass Gas Chromatography,Spectrometry-Gas Chromatography, Mass,Spectrum Analysis, Mass Gas Chromatography
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003704 Dementia An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness. Senile Paranoid Dementia,Amentia,Familial Dementia,Amentias,Dementia, Familial,Dementias,Dementias, Familial,Dementias, Senile Paranoid,Familial Dementias,Paranoid Dementia, Senile,Paranoid Dementias, Senile,Senile Paranoid Dementias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D001679 Biogenic Amines A group of naturally occurring amines derived by enzymatic decarboxylation of the natural amino acids. Many have powerful physiological effects (e.g., histamine, serotonin, epinephrine, tyramine). Those derived from aromatic amino acids, and also their synthetic analogs (e.g., amphetamine), are of use in pharmacology. Amines, Biogenic,Biogenic Amine,Amine, Biogenic

Related Publications

J Herranen, and A Huhtikangas, and H Tirronen, and T Halonen, and M Huuskonen, and K Reinikainen, and P Riekkinen
November 1974, Journal of chromatography,
J Herranen, and A Huhtikangas, and H Tirronen, and T Halonen, and M Huuskonen, and K Reinikainen, and P Riekkinen
December 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
J Herranen, and A Huhtikangas, and H Tirronen, and T Halonen, and M Huuskonen, and K Reinikainen, and P Riekkinen
January 1972, Analytical biochemistry,
J Herranen, and A Huhtikangas, and H Tirronen, and T Halonen, and M Huuskonen, and K Reinikainen, and P Riekkinen
January 1990, Journal of pharmaceutical and biomedical analysis,
J Herranen, and A Huhtikangas, and H Tirronen, and T Halonen, and M Huuskonen, and K Reinikainen, and P Riekkinen
April 1977, Analytical biochemistry,
J Herranen, and A Huhtikangas, and H Tirronen, and T Halonen, and M Huuskonen, and K Reinikainen, and P Riekkinen
January 1992, Journal of neurochemistry,
J Herranen, and A Huhtikangas, and H Tirronen, and T Halonen, and M Huuskonen, and K Reinikainen, and P Riekkinen
December 1989, Journal of neurochemistry,
J Herranen, and A Huhtikangas, and H Tirronen, and T Halonen, and M Huuskonen, and K Reinikainen, and P Riekkinen
March 1983, Biomedical mass spectrometry,
J Herranen, and A Huhtikangas, and H Tirronen, and T Halonen, and M Huuskonen, and K Reinikainen, and P Riekkinen
April 1991, Journal of chromatography,
J Herranen, and A Huhtikangas, and H Tirronen, and T Halonen, and M Huuskonen, and K Reinikainen, and P Riekkinen
November 1974, Journal of chromatographic science,
Copied contents to your clipboard!